Monitor for further insider selling filings and any material news that could explain the accelerated selling. The pattern suggests potential lack of confidence from a former officer; traders may consider reducing exposure or hedging ahead of any upcoming catalysts.
Price Chart
Executive Summary
Former officer Aziz Mottiwala filed a Form 144 notice to sell 77,698 shares (~$5.75M) of Tarsus Pharmaceuticals on September 1, 2026, following two recent large sales totaling ~$9.68M on August 19 and August 25. This pattern of accelerated insider selling by a former officer raises concern about insider sentiment despite strong analyst consensus.
Key Facts
- Aziz Mottiwala, a former officer, filed Form 144 to sell 77,698 shares of common stock.
- Estimated aggregate market value of proposed sale: $5,746,846.04.
- Shares acquired via stock option exercise on the same date (September 1, 2026).
- Mottiwala previously sold 53,043 shares on August 19, 2026, and 81,332 shares on August 25, 2026.
- Total insider sales by Mottiwala in the past two weeks exceed $15 million.
- Market cap of TARS is ~$3.3B; proposed sale represents ~0.17% of market cap.
Financial Impact
Proposed sale of 77,698 shares valued at ~$5.75M; combined with recent sales totals ~$15.4M in two weeks.
Risk Factors
- Continued insider selling could signal deteriorating confidence in the company's near-term prospects.
- Large option-exercise sales may indicate the insider is monetizing equity ahead of a potential downturn.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-006607 |
| Document: 0001959173-26-006607-index.html | 0001959173-26-006607 |
| Document: 0001959173-26-006607.txt | 0001959173-26-006607 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Insider Cluster | $82.77 $77.64 | ▼ −6.20% | ▼ −5.54% | $73.61 (−11.06%) |
Sep 3, 2026 29d ago | Insider Cluster | $83.21 $79.31 | ▼ −4.68% | ▼ −3.53% | $73.61 (−11.53%) |
Sep 2, 2026 29d ago | 144 | $82.76 $81.12 | ▲ +1.98% | ▲ +1.02% | $73.61 (+11.05%) |
Sep 1, 2026 4w ago | 144 | $82.76 $81.12 | ▲ +1.98% | ▲ +1.02% | $73.61 (+11.05%) |
Aug 19, 2026 6w ago | 144 | $73.44 $70.65 | ▼ −3.80% | ▼ −3.41% | $73.61 (+0.24%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.61 (+12.68%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.61 (+12.68%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.61 (+12.68%) |
Aug 6, 2026 8w ago | Press Release | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.61 (+12.68%) |
Aug 6, 2026 8w ago | Press Release | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.61 (+12.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access